Journal article

Explorations of Agonist Selectivity for the α9*nAChR with Novel Substituted Carbamoyl/Amido/Heteroaryl Dialkylpiperazinium Salts and Their Therapeutic Implications in Pain and Inflammation


Authors listAndleeb, Hina; Papke, Roger L.; Stokes, Clare; Richter, Katrin; Herz, Sara M.; Chiang, Ka; Kanumuri, Siva R. Raju; Sharma, Abhisheak; Damaj, M. Imad; Grau, Veronika; Horenstein, Nicole A.; Thakur, Ganesh A.

Publication year2024

Pages8642-8666

JournalJournal of Medicinal Chemistry

Volume number67

Issue number11

ISSN0022-2623

eISSN1520-4804

Open access statusHybrid

DOI Linkhttps://doi.org/10.1021/acs.jmedchem.3c02429

PublisherAmerican Chemical Society


Abstract
There is an urgent need for nonopioid treatments for chronic and neuropathic pain to provide effective alternatives amid the escalating opioid crisis. This study introduces novel compounds targeting the alpha 9 nicotinic acetylcholine receptor (nAChR) subunit, which is crucial for pain regulation, inflammation, and inner ear functions. Specifically, it identifies novel substituted carbamoyl/amido/heteroaryl dialkylpiperazinium iodides as potent agonists selective for human alpha 9 and alpha 9 alpha 10 over alpha 7 nAChRs, particularly compounds 3f, 3h, and 3j. Compound 3h (GAT2711) demonstrated a 230 nM potency as a full agonist at alpha 9 nAChRs, being 340-fold selective over alpha 7. Compound 3c was 10-fold selective for alpha 9 alpha 10 over alpha 9 nAChR. Compounds 2, 3f, and 3h inhibited ATP-induced interleukin-1 beta release in THP-1 cells. The analgesic activity of 3h was fully retained in alpha 7 knockout mice, suggesting that analgesic effects were potentially mediated through alpha 9* nAChRs. Our findings provide a blueprint for developing alpha 9*-specific therapeutics for pain.



Citation Styles

Harvard Citation styleAndleeb, H., Papke, R., Stokes, C., Richter, K., Herz, S., Chiang, K., et al. (2024) Explorations of Agonist Selectivity for the α9*nAChR with Novel Substituted Carbamoyl/Amido/Heteroaryl Dialkylpiperazinium Salts and Their Therapeutic Implications in Pain and Inflammation, Journal of Medicinal Chemistry, 67(11), pp. 8642-8666. https://doi.org/10.1021/acs.jmedchem.3c02429

APA Citation styleAndleeb, H., Papke, R., Stokes, C., Richter, K., Herz, S., Chiang, K., Kanumuri, S., Sharma, A., Damaj, M., Grau, V., Horenstein, N., & Thakur, G. (2024). Explorations of Agonist Selectivity for the α9*nAChR with Novel Substituted Carbamoyl/Amido/Heteroaryl Dialkylpiperazinium Salts and Their Therapeutic Implications in Pain and Inflammation. Journal of Medicinal Chemistry. 67(11), 8642-8666. https://doi.org/10.1021/acs.jmedchem.3c02429



Keywords


ALPHA-9CONOTOXINNICOTINIC ACETYLCHOLINE-RECEPTORSRGIA

Last updated on 2025-10-06 at 12:06